Policy / Pricing FDA Policy Tracker 2026: Psychedelics get a boost BioSpaceA year of significant policy change at the FDA brought momentum and scrutiny into the new year.Policy / PricingNeuroscienceRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) BioSpace A year of significant policy change at the FDA brought momentum and scrutiny into the new year. Policy / PricingNeuroscienceRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: UK Knowledge Quarter welcomes Boehringer Ingelheim AI acceleratorNext: Beyond GLP-1Rs: emerging targets poised to gain share of obesity market Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
